(Q35074313)

6 August 2017

1 reference

title

Autoimmune lymphoproliferative syndrome: etiology, diagnosis, and management (English)

1 reference

autoimmune lymphoproliferative syndrome

6 August 2017

main subject

0 references

author name string

Jutte van der Werff ten Bosch

series ordinal

1

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

185-193

1 reference

https://scigraph.springernature.com/pub.10.2165/00128072-200305030-00005

6 August 2017

exact match

0 references

cites work

Fas ligation induces apoptosis of CD40-activated human B lymphocytes

1 reference

12 December 2020

Clinical, immunological, and pathological consequences of Fas-deficient conditions

1 reference

12 December 2020

Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease

1 reference

12 December 2020

Germline FAS gene mutation in a case of ALPS and NLP Hodgkin lymphoma

1 reference

12 December 2020

Description of serologic features in autoimmune lymphoproliferative syndrome.

1 reference

12 December 2020

Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

1 reference

12 December 2020

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains

1 reference

12 December 2020

Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity

1 reference

12 December 2020

Chronic lymphadenopathy simulating malignant lymphoma

1 reference

12 December 2020

Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen

1 reference

12 December 2020

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

1 reference

12 December 2020

Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis

1 reference

12 December 2020

Autoimmune lymphoproliferative syndrome, a disorder of apoptosis

1 reference

12 December 2020

Investigation of suspected deficient Fas-mediated apoptosis in a father and son

1 reference

12 December 2020

Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations

1 reference

12 December 2020

A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen

1 reference

12 December 2020

Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation

1 reference

12 December 2020

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

1 reference

12 December 2020

Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo

1 reference

12 December 2020

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

1 reference

12 December 2020

Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis

1 reference

12 December 2020

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

1 reference

12 December 2020

Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal.

1 reference

12 December 2020

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease

1 reference

12 December 2020

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

1 reference

12 December 2020

Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.

1 reference

12 December 2020

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

1 reference

12 December 2020

Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo

1 reference

12 December 2020

Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features

1 reference

12 December 2020

Autoimmune lymphoproliferative syndrome type III: an indefinite disorder

1 reference

12 December 2020

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome

1 reference

12 December 2020

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

1 reference

12 December 2020

Familial splenomegaly syndrome with reduced circulating T helper cells and splenic germinal centre hypoplasia

1 reference

12 December 2020

Dyserythropoiesis associated with a Fas-deficient condition in childhood

1 reference

12 December 2020

Revision of the diagnosis of T-zone lymphoma in the father of a patient with autoimmune lymphoproliferative syndrome type II.

1 reference

12 December 2020

TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis

1 reference

12 December 2020

Pathological findings in human autoimmune lymphoproliferative syndrome

1 reference

12 December 2020

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency

1 reference

12 December 2020

Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor

1 reference

12 December 2020

The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis

1 reference

12 December 2020

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival

1 reference

12 December 2020

Caspases: intracellular signaling by proteolysis

1 reference

12 December 2020

Diffuse large B-cell non-Hodgkin's lymphoma in a patient with autoimmune lymphoproliferative syndrome

1 reference

12 December 2020

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis

1 reference

12 December 2020

Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity

1 reference

12 December 2020

Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.

1 reference

12 December 2020

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis

1 reference

12 December 2020

Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.

1 reference

12 December 2020

Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency

1 reference

12 December 2020

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance

1 reference

12 December 2020

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II

1 reference

12 December 2020

Report of a factor VIII inhibitor in a patient with autoimmune lymphoproliferative syndrome

1 reference

12 December 2020

Apoptosis signaling in lymphocytes.

1 reference

12 December 2020

Caspase-10 is an initiator caspase in death receptor signaling

1 reference

12 December 2020

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome

1 reference

12 December 2020

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease

1 reference

12 December 2020

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations

1 reference

12 December 2020

Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer

1 reference

12 December 2020

Autoimmune hemolytic anemia as a manifestation of T-suppressor-cell deficiency

1 reference

12 December 2020

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

1 reference

12 December 2020

Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?

1 reference

12 December 2020

Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder

1 reference

12 December 2020

Paucity of splenic germinal centers: a new and unique splenomegaly syndrome including dysfunctional immune system

1 reference

12 December 2020

Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens

1 reference

12 December 2020

The use of the anti-malaria drug Fansidar (pyrimethamine and sulphadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency

1 reference

12 December 2020

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression

1 reference

12 December 2020

Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.

1 reference

12 December 2020

10.2165/00128072-200305030-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

1038896731

0 references

1 reference